Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis

Autor:	Carlos Tajer, Shaun G. Goodman, Stephen J. Nicholls, Germán Málaga, Harvey D. White, Jose C. Nicolau, Lucas P. Damiani, Denise M. Paisani, Renato D. Lopes, Francisco Antonio Helfenstein Fonseca, Otavio Berwanger, Alexander Parkhomenko, Lixin Jiang, Pedro Gabriel Melo de Barros e Silva, Leopoldo S. Piegas, Nanci Valeis, Tamiris A Miranda, Renato Hideo Nakagawa Santos, Hélio Penna Guimarães, Christopher B. Granger, Oleg Averkov, José Francisco Kerr Saraiva, Diogo D.F. Moia
Rok vydání:	2019
Předmět:	medicine.medical_specialty business.industry medicine.medical_treatment 030204 cardiovascular system & hematology medicine.disease Clopidogrel 03 medical and health sciences 0302 clinical medicine Internal medicine Fibrinolysis medicine Cardiology In patient cardiovascular diseases 030212 general & internal medicine Myocardial infarction Fibrinolytic therapy Cardiology and Cardiovascular Medicine business Ticagrelor medicine.drug
Zdroj:	Journal of the American College of Cardiology. 73:2819-2828
ISSN:	0735-1097
Popis:	Background: The efficacy of ticagrelor in the long-term post–ST-segment elevation myocardial infarction (STEMI) treated with fibrinolytic therapy remains uncertain.Objectives: The purpose o...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9c6bdc76cbbc2a5e46e520cddbf0d03f https://doi.org/10.1016/j.jacc.2019.03.011 Zobrazit plný text záznamu